Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CTLT Catalent > Detailed Quotes

CTLT Catalent

Watchlist
53.650
+1.380+2.64%
Close  01/27 16:00 ET
53.6500.0000.00%
Post Mkt Price 01/27 16:03 ET
High
54.120
Open
52.250
Turnover
92.98M
Low
51.930
Pre Close
52.270
Volume
1.75M
Market Cap
9.66B
P/E(TTM)
22.83
52wk High
115.335
Shares
179.96M
P/E(Static)
18.89
52wk Low
40.690
Float Cap
9.57B
Bid/Ask %
0.00%
Historical High
142.640
Shs Float
178.39M
Volume Ratio
0.71
Historical Low
18.920
Dividend TTM
--
Div Yield TTM
--
P/B
2.05
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.98%
Amplitude
4.19%
Avg Price
53.201
Lot Size
1
Float Cap
9.57B
Bid/Ask %
0.00%
Historical High
142.640
Shs Float
178.39M
Volume Ratio
0.71
Historical Low
18.920
Dividend TTM
--
P/B
2.05
Dividend LFY
--
Turnover Ratio
0.98%
Amplitude
4.19%
Avg Price
53.201
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory management of drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.
CEO: Mr. Alessandro Maselli
Market: NYSE
Listing Date: 07/31/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist